HalioDx

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
HalioDx is an immuno-oncology diagnostic company providing oncologists and Biopharma with first-in-class immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.
Immunoscore® proprietary technology, pioneered by Jérôme Galon at the Cordeliers Research Center, Paris, France, integrates immunohistochemistry combined with sophisticated algorithm and advanced imaging analysis enabling extraction of spatially organised tissue molecular information.
Immunoscore® is available Internationally as a CLIA or CE marked test to guide day to day oncologists’ decisions. Immunoscore® is a platform for many cancers, as immune response to tumor is a key hallmark of disease progression.
HalioDx executes biomarker studies and companion diagnostic assay development in conformity with regulations and in partnership with biopharmaceutical companies.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
France
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
Brightplex® Technology
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
EVP, Partnerships BU
HalioDx